Can a female of childbearing age with Attention Deficit Hyperactivity Disorder (ADHD) take Vyvanse (lisdexamfetamine) with Yasmin (drospirenone and ethinyl estradiol) and Lion's Mane (Hericium erinaceus) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vyvanse with Yasmin and Lion's Mane: Drug Interaction Assessment

Yes, Vyvanse can be taken with Yasmin (oral contraceptive) and Lion's Mane mushroom supplement, as there are no documented pharmacokinetic or pharmacodynamic interactions between these agents that would contraindicate their concurrent use.

Vyvanse and Yasmin Combination

No clinically significant drug interactions exist between lisdexamfetamine (Vyvanse) and combined oral contraceptives containing drospirenone and ethinyl estradiol (Yasmin).

  • Lisdexamfetamine is a prodrug that is enzymatically hydrolyzed in the blood to release active d-amphetamine, which then acts on dopamine and norepinephrine transporters in the CNS 1, 2
  • The metabolism of lisdexamfetamine occurs through rate-limited hydrolysis in the gastrointestinal tract and blood, not through hepatic cytochrome P450 enzymes 2, 3
  • Yasmin's metabolism occurs primarily through hepatic pathways that do not overlap with amphetamine metabolism
  • No adjustments to either medication are needed when used together

Important Monitoring Considerations

  • Cardiovascular effects: Both stimulants and oral contraceptives can independently affect blood pressure; monitor blood pressure regularly when using both medications concurrently
  • Pregnancy planning: If pregnancy is being considered, be aware that amphetamines cross the placental barrier and may be associated with small increased risks for gastroschisis (adjusted OR 3.0; 95% CI, 1.2-7.4) and preeclampsia (adjusted RR 1.29; 95% CI, 1.11-1.49) 4

Vyvanse and Lion's Mane Combination

Lion's Mane mushroom (Hericium erinaceus) can be taken with Vyvanse, as there are no documented interactions between this natural supplement and amphetamine-based medications.

  • Lion's Mane is a dietary supplement with purported cognitive benefits but lacks rigorous pharmacokinetic interaction studies with prescription medications
  • No evidence exists suggesting Lion's Mane affects amphetamine metabolism or efficacy
  • The mechanism of action of d-amphetamine (competitive inhibition of dopamine and norepinephrine transporters, plus promotion of neurotransmitter release) is unlikely to be significantly altered by Lion's Mane constituents 1

Practical Considerations

  • Start Lion's Mane separately from initiating Vyvanse to distinguish any side effects attributable to each agent
  • Monitor for any unexpected changes in ADHD symptom control or emergence of new symptoms

Common Pitfalls to Avoid

  • Do not assume herbal supplements are risk-free: While Lion's Mane appears safe with Vyvanse, always disclose all supplements to your prescriber
  • Avoid high-fat meals with Vyvanse: Food can affect absorption of stimulant medications; maintain consistent timing relative to meals 5
  • Monitor for substance misuse risk: Lisdexamfetamine has lower abuse potential than immediate-release amphetamines due to its prodrug design, but diversion remains a concern in adolescents and young adults 6, 2
  • Watch for common stimulant side effects: Appetite suppression, insomnia, and headache occur in >10% of patients and may require dose or timing adjustments 7

Special Considerations for Women of Childbearing Age

  • Yasmin provides reliable contraception, which is important given the potential pregnancy risks associated with amphetamine exposure 4
  • If pregnancy occurs, amphetamines do not appear associated with major congenital malformations or cardiac defects, though small risks for specific outcomes exist 4
  • Consider non-pharmacological ADHD interventions if pregnancy is planned 4

References

Research

Lisdexamfetamine.

Paediatric drugs, 2007

Research

Lisdexamfetamine dimesylate for childhood ADHD.

Drugs of today (Barcelona, Spain : 1998), 2008

Guideline

Placental Transfer of Vyvanse

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Converting Vyvanse to Concerta

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.